Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|September 15, 2005
Roles of the threonine 407, aspartic acid 417, and threonine 419 residues in P450 2B1 in metabolismChitra Sridar, Erin Harleton, Paul F HollenbergDrug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2012
Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adductsChitra Sridar, Cesar Kenaan, Paul F HollenbergXenobiotica; the Fate of Foreign Compounds in Biological Systems|September 5, 2012
Quantitation of UGT1A1 in human liver microsomes using stable isotope-labelled peptides and mass spectrometry based proteomic approachesChitra Sridar, Imad Hanna, Paul F HollenbergDrug Metabolism and Disposition: the Biological Fate of Chemicals|September 4, 2012
Bioactivation of the cancer chemopreventive agent tamoxifen to quinone methides by cytochrome P4502B6 and identification of the modified residue on the apoproteinChitra Sridar, Jaime D'Agostino, Paul F HollenbergDrug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2011
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6Chitra Sridar, Natasha T Snider, Paul F HollenbergThe Journal of Pharmacology and Experimental Therapeutics|June 5, 2004
Identification of amino acid residues involved in the inactivation of cytochrome P450 2B1 by two acetylenic compounds: the role of three residues in nonsubstrate recognition SitesLinda B Von Weymarn, Chitra Sridar, Paul F HollenbergChemical Research in Toxicology|August 30, 2008
Modification of serine 360 by a reactive intermediate of 17-alpha-ethynylestradiol results in mechanism-based inactivation of cytochrome P450s 2B1 and 2B6Ute M Kent, Chitra Sridar, Greg Spahlinger, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 2, 2013
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivationYasushi Yoshigae, Chitra Sridar, Ute M Kent, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 17, 2005
The naturally occurring cytochrome P450 (P450) 2B6 K262R mutant of P450 2B6 exhibits alterations in substrate metabolism and inactivationNamandjé N Bumpus, Chitra Sridar, Ute M Kent, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 25, 2004
Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferasesChitra Sridar, Theunis C Goosen, Ute M Kent, et al.Pageof 2